Allergy Therapeutics
AGY.L
#6087
Rank
A$1.39 B
Marketcap
A$0.23
Share price
3.67%
Change (1 day)
81.66%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2024: -A$74.87 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are A$69.81 Million. In 2024 the company made an earning of -A$74.87 Million, an increase over its 2023 earnings that were of -A$80.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2024

Annual earnings

Year Earnings Change
2024-A$74.87 Million-6.69%
2023-A$80.24 Million244.94%
2022-A$23.27 Million-404.35%
2021A$7.64 M-49.42%
2020A$15.11 M83.48%
2019A$8.23 M-159.83%
2018-A$13.77 Million255.48%
2017-A$3.88 Million-84.06%
2016-A$24.3 Million-1667.33%
2015A$1.55 M-44.68%
2014A$2.8 M130.59%
2013A$1.21 M-19.89%
2012A$1.51 M-127.05%
2011-A$5.61 Million2009.96%
2010-A$0.27 Million-99.07%
2009-A$28.49 Million-53.23%
2008-A$60.9 Million-21.86%
2007-A$77.94 Million356.94%
2006-A$17.06 Million230.75%
2005-A$5.16 Million-217.9%
2004A$4.37 M-58.79%
2003A$10.61 M-196.03%
2002-A$11.06 Million